New research appearing in the Journal of the National Comprehensive Cancer Network found that incorporating information from ...
5hon MSN
Clinical trial explores whether a genetic test can improve early detection of prostate cancer
A genetic test developed by researchers at Broad Clinical Labs and the U.S. Department of Veterans Affairs (VA) is now enabling a large, nationwide clinical trial aimed at improving health care for ...
The Food and Drug Administration recently approved the IsoPSA blood test, which was developed by Cleveland Diagnostics, a ...
Prostate cancer is one of the most common and deadly forms of cancer in men, yet early detection remains a major challenge. That difficulty lies in how subtle the disease can be in its earliest stages ...
The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...
Is the Galleri multi-cancer blood test worth it? A doctor explains real-world performance data and explains why no major ...
WASHINGTON D.C. (WPVI) -- The Preventive Services Task Force is changing recommendations that can affect millions of middle-aged men. Five years ago, it opposed routine screening for prostate cancer, ...
A prostate-specific antigen (PSA) test is a blood test that measures a protein released in the blood by prostate cells. Both normal and cancerous prostate cells release the protein. Most of the time, ...
NFL tight ends and prostate cancer survivor Bruce Arians star in a Super Bowl commercial promoting a new, finger-free PSA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results